Kim Mee-Seon, Lee Hyoun Wook, Lee Eun Hee
Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine Changwon, South Korea.
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9383-9. eCollection 2015.
In human, proximal convoluted tubules and thin limbs of Henle show expression of αB crystallin. Renal cell carcinoma also showed expression of αB crystallin in previous reports. We aimed to study the association between αB crystallin expression and renal cell carcinoma and urothelial carcinoma. Furthermore, we also investigated αB crystallin expression depending on the subtype of renal cell carcinoma and examined the relationship between αB crystallin expression and survival in patients with renal cell carcinoma. In our study, αB crystallin expression was different according to the type of tumor. A greater proportion of the clear cell type (52/77, 67.5%) and papillary type (4/4, 100%) showed reactivity compared to the chromophobe type (0/10, 0%). In the present study, a significantly greater number of renal cell carcinomas showed strong expression of αB crystallin (56/91, 61.5%) compared to urothelial carcinoma (P=7.967e-07). Therefore, αB crystallin might be a significant marker of renal cell carcinoma and might help to determine the type of renal tumor in cases of poorly differentiated kidney lesions and metastatic lesions. αB crystallin expression was not related to overall survival in univariate and multivariate models. In our study, alpha B crystallin could not be considered a prognostic marker of renal cell carcinoma.
在人类中,近端曲管和髓袢细段显示有αB晶状体蛋白的表达。既往报道显示肾细胞癌也有αB晶状体蛋白的表达。我们旨在研究αB晶状体蛋白表达与肾细胞癌和尿路上皮癌之间的关联。此外,我们还根据肾细胞癌的亚型研究了αB晶状体蛋白的表达情况,并探讨了αB晶状体蛋白表达与肾细胞癌患者生存率之间的关系。在我们的研究中,αB晶状体蛋白的表达因肿瘤类型而异。与嫌色细胞型(0/10,0%)相比,透明细胞型(52/77,67.5%)和乳头状型(4/4,100%)中有更大比例显示出反应性。在本研究中,与尿路上皮癌相比,有显著更多的肾细胞癌显示出αB晶状体蛋白的强表达(56/91,61.5%)(P = 7.967×10⁻⁷)。因此,αB晶状体蛋白可能是肾细胞癌的一个重要标志物,并且在低分化肾病变和转移病变的病例中可能有助于确定肾肿瘤的类型。在单变量和多变量模型中,αB晶状体蛋白表达与总生存率无关。在我们的研究中,αB晶状体蛋白不能被视为肾细胞癌的预后标志物。